Hyperactive deoxy-PIEZO1 shapes the circulatory life cycle of irreversibly sickled cells
- PMID: 39924881
- PMCID: PMC12044392
- DOI: 10.1016/j.bpj.2025.02.005
Hyperactive deoxy-PIEZO1 shapes the circulatory life cycle of irreversibly sickled cells
Abstract
Sickle cell disease (SCD), affecting millions worldwide, is caused by the homozygous inheritance of the abnormal hemoglobin HbS. Deoxygenation of HbS in the venous circulation permeabilizes sickle cells to calcium via PIEZO1 channels, triggering a dehydration cascade driven by the outward electrochemical potassium gradient. This mechanism operates with particular intensity in a subpopulation of sickle red blood cells (RBCs), the irreversibly sickled cells (ISCs). The lifespan of ISCs is extremely short, about 4-7 days. Most of this time is spent in a profoundly dehydrated condition, the irreversibly sickled state, eliciting vaso-occlusion, which is considered the root cause of organ failure and pain crisis in SCD. There is a large experimental and clinical database on sickle cells and ISCs, but how ISCs form and evolve in the circulation remains a mystery. The present study is the first attempt to unravel the experimentally inaccessible life cycle of ISCs in vivo by applying a well-accredited model of RBC homeostasis and circulatory dynamics, using a vast array of validated experimental observations to tightly constrain the model parameters. The results showed that abnormally strong deoxy-PIEZO1 responses were needed for calcium to elicit a violent hyperdense collapse in ISC-destined stress reticulocytes within about a day in the circulation. The potassium-depleted ISCs remain in this maximally dehydrated but volume-stable condition, the pathogenic state, sustained by vigorous pump-leak balanced sodium fluxes. Eventually, sodium pump decay initiates rapid terminal rehydration by the unbalanced net gain of NaCl and water. Analysis of the mechanisms behind this three-stage circulatory life cycle of ISCs exposed a complex web of interactions among many components of the homeostatic fabric of RBCs. These findings point to the abnormally intense PIEZO1 response to deoxygenation in ISC-destined stress reticulocytes as a prime cause of ISC formation in vivo, a central target for future research.
Copyright © 2025 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
Similar articles
-
Novel single-cell measurements suggest irreversibly sickled cells are neither dense nor dehydrated.Biophys J. 2024 Nov 5;123(21):3750-3758. doi: 10.1016/j.bpj.2024.09.024. Epub 2024 Sep 26. Biophys J. 2024. PMID: 39327732
-
Hydroxyurea (hydroxycarbamide) for sickle cell disease.Cochrane Database Syst Rev. 2017 Apr 20;4(4):CD002202. doi: 10.1002/14651858.CD002202.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2022 Sep 1;9:CD002202. doi: 10.1002/14651858.CD002202.pub3. PMID: 28426137 Free PMC article. Updated.
-
Hydroxyurea (hydroxycarbamide) for sickle cell disease.Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3. Cochrane Database Syst Rev. 2022. PMID: 36047926 Free PMC article.
-
Preoperative blood transfusions for sickle cell disease.Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 Jul 2;7:CD003149. doi: 10.1002/14651858.CD003149.pub4. PMID: 27049331 Free PMC article. Updated.
-
Magnesium for treating sickle cell disease.Cochrane Database Syst Rev. 2017 Apr 14;4(4):CD011358. doi: 10.1002/14651858.CD011358.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Sep 09;9:CD011358. doi: 10.1002/14651858.CD011358.pub3. PMID: 28409830 Free PMC article. Updated.
Cited by
-
The brief life-story of irreversibly sickled cells.Biophys J. 2025 Apr 15;124(8):1179-1182. doi: 10.1016/j.bpj.2025.03.003. Epub 2025 Mar 10. Biophys J. 2025. PMID: 40070119 No abstract available.
References
-
- Shen S.C., Fleming E.M., et al. Castle W.B. Studies on the destruction of red blood cells. V. Irreversibly sickled erythrocytes: Their experimental production in vitro. Blood. 1949;4:498–504. - PubMed
-
- Bertles J.F., Rabinowitz R., Döbler J. Hemoglobin interaction: Modification of solid phase composition in the sickling phenomenon. Science. 1970;169:375–377. - PubMed
-
- Bunn H.F., Forget B.G. W.B.Saunders Company; Philadelphia: 1986. Hemoglobin: Molecular, Genetic and Clinical Aspects.
-
- Kaul D.K., Fabry M.E., Nagel R.L. Vaso-occlusion by sickle cells: evidence for selective trapping of dense red cells. Blood. 1986;68:1162–1166. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical